Literature DB >> 8665501

Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.

M Nagatake1, Y Takagi, H Osada, K Uchida, T Mitsudomi, S Saji, K Shimokata, T Takahashi, T Takahashi.   

Abstract

The chromosome region 18q21 has been shown to be frequently deleted in lung cancers. Recent identification at this locus of DPC4, a gene whose inactivation has been suggested to play a role in pancreatic carcinogenesis, prompted as to examine whether it might also be altered in lung cancers. Two missense and 2-bp frameshift somatic mutations in DPC4 were detected among 42 lung cancer specimens taken directly from patients. DPC4 mutations, however, were not present in all lung cancers carrying l8q21 deletions. These findings suggest that DPC4 may play a role in a limited fraction of lung cancers and that another tumor suppressor gene may also exist in this chromosome region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665501

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

2.  TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.

Authors:  X Shen; P P Hu; N T Liberati; M B Datto; J P Frederick; X F Wang
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

3.  Determinants of specificity in TGF-beta signal transduction.

Authors:  Y G Chen; A Hata; R S Lo; D Wotton; Y Shi; N Pavletich; J Massagué
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

Review 4.  Targeting TGF-β signaling in cancer.

Authors:  Lior H Katz; Ying Li; Jiun-Sheng Chen; Nina M Muñoz; Avijit Majumdar; Jian Chen; Lopa Mishra
Journal:  Expert Opin Ther Targets       Date:  2013-05-07       Impact factor: 6.902

5.  Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk.

Authors:  Ana L Teixeira; António Araújo; Ana Coelho; Ricardo Ribeiro; Mónica Gomes; Carina Pereira; Rui Medeiros
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-07       Impact factor: 4.553

6.  Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction.

Authors:  M B Datto; J P Frederick; L Pan; A J Borton; Y Zhuang; X F Wang
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Sequence and chromosomal mapping of the mouse homolog (Madh4) of the human DPC4/MADH4 gene.

Authors:  C H Anna; T R Devereux
Journal:  Mamm Genome       Date:  1997-06       Impact factor: 2.957

8.  Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.

Authors:  F Liu; C Pouponnot; J Massagué
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

9.  Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.

Authors:  Shih-Chang Chuang; King-Teh Lee; Kun-Bow Tsai; Pai-Ching Sheen; Eishi Nagai; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

10.  Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.

Authors:  Flavia R R Mangone; Fernando Walder; Simone Maistro; Fátima S Pasini; Carlos N Lehn; Marcos B Carvalho; M Mitzi Brentani; Igor Snitcovsky; Miriam H H Federico
Journal:  Mol Cancer       Date:  2010-05-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.